The global gene identification tools market is witnessing rapid growth as researchers and clinicians use advanced genomic technologies to identify disease-causing genes and potential therapeutic targets. The increased prevalence of infectious diseases has boosted demand for gene identification tools, driving the global gene identification tools market.
The global foley catheters market size was calculated at USD 1.87 billion in 2024 and is predicted to increase from USD 1.98 billion in 2025 to approximately USD 3.33 billion by 2034, expanding at a CAGR of 5.94% from 2025 to 2034. The growth of the Foley catheters market is driven by rising prevalence of urological disorders, growing elderly population, and increasing demand for long-term urinary catheterization in hospitals and home care settings.
The global enzyme engineering market is witnessing rapid growth as industries utilize engineered enzymes to improve efficiency in pharmaceuticals, food processing, and biofuels. The market is witnessing robust growth driven by growing demand in the pharmaceutical & diagnostic sector, rising focus on sustainable practices across various industries, increasing demand for processed foods & beverages, growing investments in research and development activities, and rapid advancements in enzyme engineering.
The global biomanufacturing specialty chemicals market size is estimated at USD 12.39 billion in 2025. It is projected to increase from USD 13.51 billion in 2026 to approximately USD 26.99 billion by 2034, growing at a CAGR of 9.04% from 2025 to 2034. The global biomanufacturing specialty chemicals market is witnessing strong growth as pharmaceutical and biotech companies rely on specialized chemicals to support biologics and cell therapy production. This market is growing due to increasing demand across multiple end-use industries, rapid industrialization in emerging economies, and a global shift toward sustainable and bio-based products.
The global microbiome therapeutics market size was calculated at USD 187.13 million in 2024 and is predicted to increase from USD 250.06 million in 2025 to approximately USD 3,405.99 million by 2034, expanding at a CAGR of 33.67% from 2025 to 2034. The market growth is attributed to increasing investment in advanced microbiome research and expanding applications of microbiome-based therapies in treating complex diseases.
The global 3D protein structures analysis market size accounted for USD 2.80 billion in 2024 and is predicted to increase from USD 3.06 billion in 2025 to approximately USD 6.88 billion by 2034, expanding at a CAGR of 9.40% from 2025 to 2034. The growth of the market is driven by rising demand for structure-based drug design, advancements in imaging technologies, and growing focus on precision medicine.
The global gene identification market is witnessing rapid growth as next-generation sequencing and computational biology accelerate discovery of disease-causing genes. The growth of the market is driven by rising demand for precision medicine, advances in sequencing technologies, and expanding applications across healthcare and research.
The global internal neuromodulation devices market size accounted for USD 11.82 billion in 2024 and is predicted to increase from USD 13.61 billion in 2025 to approximately USD 48.45 billion by 2034, expanding at a CAGR of 15.15% from 2025 to 2034.
The global endoscopic spinal surgery equipment market is witnessing rapid growth as surgeons increasingly adopt minimally invasive techniques for spinal disorders, offering improved outcomes and shorter recovery times. The market growth is driven by rising demand for minimally invasive procedures, technological advancements, and the increasing prevalence of spinal disorders.
The global capsule endoscopy market size accounted for USD 443.84 million in 2024 and is predicted to increase from USD 479.13 billion in 2025 to approximately USD 953.79 million by 2034, expanding at a CAGR of 7.95% from 2025 to 2034. The market is gaining traction due to technological advancements in capsule design, battery life, and imaging resolution, which are propelling the market forward.
The global auricular bioelectronic devices market is witnessing rapid growth as wearable ear-based devices provide non-invasive neurostimulation, monitoring, and therapeutic applications for neurological and wellness needs. The market is driven by the rising adoption of wearable health technologies, increasing demand for non-invasive diagnostics, and advancements in bioelectronic medicine targeting ear-based neural pathways.
The global intravascular lithotripsy market size was calculated at USD 0.93 billion in 2024 and is predicted to increase from USD 1.07 billion in 2025 to approximately USD 3.93 billion by 2034, expanding at a CAGR of 15.57% from 2025 to 2034. The AAV gene therapy market is driven by rising approvals, expanding therapeutic applications, and increasing investments in advanced genetic treatment innovations.
The global medical holographic imaging market is witnessing rapid growth as hospitals and clinics adopt 3D holographic technology to enhance diagnostics, surgical planning, and medical education. The global market is experiencing significant growth, driven by increased demand for minimally invasive procedures.
The global nanorobots in healthcare market size was calculated at USD 7.27 billion in 2024 and is predicted to increase from USD 7.72 billion in 2025 to approximately USD 13.21 billion by 2034, expanding at a CAGR of 6.15% from 2025 to 2034. The market growth is attributed to the increasing prevalence of chronic diseases, rising investment in research and development that leverage precision-targeted nanorobotic technologies.
The global wireless neurostimulators market is witnessing rapid growth as wireless, minimally invasive neuromodulation devices improve treatment outcomes for chronic pain, movement disorders, and other neurological conditions. Implantable and wearable neurostimulation systems, along with supporting hardware/software, that deliver electrical or neuromodulator signals wirelessly.
The global energy-based aesthetic devices market size was estimated at USD 7.31 billion in 2024 and is predicted to increase from USD 8.35 billion in 2025 to approximately USD 27.65 billion by 2034, expanding at a CAGR of 14.23% from 2025 to 2034.
The global AAV gene therapy market size was calculated at USD 2,142 million in 2024 and is predicted to increase from USD 2,853.36 million in 2025 to approximately USD 23,546.27 million by 2034, expanding at a CAGR of 26.43% from 2025 to 2034. The market is driven by rising approvals, expanding therapeutic applications, and increasing investments in advanced genetic treatment innovations.
The global non-surgical skin tightening market size accounted for USD 3.24 billion in 2024 and is predicted to increase from USD 3.70 billion in 2025 to approximately USD 12.34 billion by 2034, expanding at a CAGR of 14.31% from 2025 to 2034.
The global skin boosters market size accounted for USD 1.41 billion in 2024 and is predicted to increase from USD 1.59 billion in 2025 to approximately USD 4.81 billion by 2034, expanding at a CAGR of 13.05% from 2025 to 2034. The skin boosters’ market is experiencing a major glow-up quite literally. As more people seek subtle, natural-looking ways to improve their skin, injectable skin boosters have quickly become a go-to treatment. These products help hydrate the skin from within, smooth out fine lines, and restore a healthy, radiant look without the need for surgery. From busy professionals to skincare enthusiasts, the demand is growing for treatments that fit into everyday life but deliver noticeable results.
The global skin rejuvenation devices market size accounted for USD 2.54 billion in 2024 and is predicted to increase from USD 2.77 billion in 2025 to approximately USD 5.99 billion by 2034, expanding at a CAGR of 8.95% from 2025 to 2034.
The global high intensity focused ultrasound market size accounted for USD 1.34 billion in 2024 and is predicted to increase from USD 1.44 billion in 2025 to approximately USD 2.7 billion by 2034, expanding at a CAGR of 7.26% from 2025 to 2034. The growth of the market is driven by rising demand for non-invasive therapeutic and aesthetic procedures, technological advancements, and increasing prevalence of chronic conditions like cancer.
The global skin cancer diagnostic market size accounted for USD 8.54 billion in 2024 and is predicted to increase from USD 8.97 billion in 2025 to approximately USD 13.96 billion by 2034, expanding at a CAGR of 5.04% from 2025 to 2034. The growth of the market is driven by the rising global incidence of skin cancer, increasing awareness of early detection, advancements in diagnostic technologies, and growing adoption of AI-based imaging tools.
The global radiofrequency-based aesthetic devices market size was calculated at USD 1.47 billion in 2024 and is predicted to increase from USD 1.63 billion in 2025 to approximately USD 4.01 billion by 2034, expanding at a CAGR of 10.56% from 2025 to 2034. The growth of the market is driven by rising demand for non-invasive cosmetic procedures, increasing awareness of skin rejuvenation, and advancements in RF technology.
The global proteomic biomarkers market is driven by advancements in mass spectrometry, bioinformatics tools, and high-throughput proteomics platforms that accelerate biomarker discovery and validation. The market is witnessing substantial growth due to rising demand for personalized medicine, especially for chronic diseases like cancer. Furthermore, increased government and private funding for research, the growing adoption of proteomics in drug discovery, and the integration of emerging technologies are driving market expansion.
The global single-cell genomics market is witnessing rapid growth as researchers use high-resolution sequencing to analyze individual cells for disease profiling and therapeutic development. The market is driven by advancements in sequencing technologies, rising applications in precision medicine, and expanding research in complex disease biology.
The global inhalation toxicology testing market size was calculated at USD 395.76 million in 2024 and is predicted to increase from USD 432.06 million in 2025 to approximately USD 982.84 million by 2034, expanding at a CAGR of 9.56% from 2025 to 2034. The increased demand for alternative testing methods and growing government funding for toxicology research are driving the global market. The market is further experiencing significant growth with rapid advancements in technology.
The global sperm cryopreservation market is witnessing steady growth as individuals and couples seek fertility preservation solutions, supported by advances in assisted reproductive technologies. The increasing rate of infertility due to poor lifestyle leading to innovation in sperm freezing methods, options for delayed parenting and delayed marriages in modern society, patients undergoing harsh chemical treatments like chemotherapy are opting for cryopreservation to save healthy sperm, are some of the key reasons for the market's growth.
The global pharmaceutical capsule filling machines market is expanding as manufacturers adopt AI-enabled monitoring, modular designs, and continuous manufacturing to enhance productivity and quality. The market is driven by rising demand for precision drug delivery, growth in generics, and increasing adoption of automated production technologies.
The global renal denervation devices market size accounted for USD 1.13 billion in 2024 and is predicted to increase from USD 1.30 billion in 2025 to approximately USD 4.49 billion by 2034, expanding at a CAGR of 14.77% from 2025 to 2034. The market is growing due to the rising prevalence of hypertension and increasing adoption of minimally invasive treatments for cardiovascular diseases.
The global estrogen replacement therapy market size was calculated at USD 11.12 billion in 2024 and is predicted to increase from USD 11.75 billion in 2025 to approximately USD 19.46 billion by 2034, expanding at a CAGR of 5.77% from 2025 to 2034. The increasing aging female population, rising awareness of post-menopausal health management, and growing adoption of bioidentical and personalized hormone therapies are expected to drive the growth of the global market for estrogen replacement therapy over the forecast period. Several key players in the market are widely adopting effective strategies like new product launches and mergers to expand their market share and gain a competitive edge. Additionally, the market is increasing in emerging regions, particularly North America, fuelled by the robust presence of pharmaceutical companies and advanced healthcare infrastructure.
The global next generation pulse oximeters market is expanding as healthcare systems focus on preventive care and telemedicine. Next-gen devices improve outcomes for chronic and acute conditions alike. The market has experienced significant growth in recent years, reflecting the increasing reliance on digital platforms for freelance and gig-based work. The next generation pulse oximeters market is emerging as a transformative segment in patient monitoring, driven by the rising need for accurate, real-time data in both hospital and home care settings.
The global neurological rare disease biologics market is witnessing rapid growth as biologic therapies target rare and complex nervous system disorders. These treatments offer new hope for underserved patient groups. The market is growing due to the increasing prevalence of rare neurological disorders and the rising adoption of targeted biologic therapies, which offer improved efficacy and safety compared to conventional treatments.
The global peptide therapeutics CDMO market continues to grow with increasing biologics R&D, strategic partnerships, and innovation in manufacturing processes. It’s reshaping peptide drug development globally. The market growth is attributed to the rising demand for targeted and effective peptide-based therapies to treat chronic and complex diseases.
The global AI-integrated CDMO process optimization market is expanding as biopharma companies seek partners with advanced digital capabilities. This trend accelerates innovation and competitiveness in outsourced production. The market is experiencing significant growth due to the increasing demand for efficient drug development and manufacturing. This growth is further supported by the adoption of machine learning and predictive analytics, which enhance quality, reduce costs, and accelerate timelines. Expanding applications in biologics, cell and gene therapies, and personalized medicine are also expected to drive market expansion.
The global cognitive neuroscience market size was calculated at USD 38.86 billion in 2024 and is predicted to increase from USD 41.44 billion in 2025 to approximately USD 73.98 billion by 2034, expanding at a CAGR of 6.65% from 2025 to 2034. The market is driven by the advancements in brain imaging technologies, the rising prevalence of neurological disorders, and the growing demand for cognitive health research and therapies.
The global health information exchange (HIE) market size accounted for USD 2.07 billion in 2024 and is predicted to increase from USD 2.27 billion in 2025 to approximately USD 5.25 billion by 2034, expanding at a CAGR of 9.75% from 2025 to 2034. The market is witnessing robust growth, driven by increasing demand for seamless data interoperability, digital healthcare adoption, and initiatives to enhance patient care efficiency.
The RNA editing therapies market is expanding as biotech firms and academic institutions invest heavily in clinical pipelines. These therapies hold potential to transform treatment landscapes for underserved diseases. The RNA editing therapies market has experienced significant growth in recent years, reflecting the increasing reliance on digital platforms for freelance and gig-based work. The RNA editing therapies market is a rapidly expanding sector driven by technological advancements and increasing demand for personalized medicine.
The rare musculoskeletal disorder treatments market is driven by rising awareness, faster diagnostics, and supportive orphan drug policies. It enables better outcomes for patients with rare, debilitating musculoskeletal diseases. The market is experiencing substantial growth due to the increasing prevalence of rare genetic musculoskeletal conditions. The market is further supported by advancements in biologics, gene therapies, and orphan drug development. Furthermore, increasing clinical research and regulatory incentives for rare disease therapies are projected to drive market expansion.
The global lymphoma treatment market size was calculated at USD 7.46 billion in 2024 and is predicted to increase from USD 8.08 billion in 2025 to approximately USD 16.62 billion by 2034, expanding at a CAGR of 8.34% from 2025 to 2034. The rapid growth of the global market, driven by advanced therapies, increased early diagnosis, and rising investment in targeted and immuno-oncology treatments.
The smart retinal implants market continues to grow with supportive regulatory pathways and collaborations between tech developers, clinicians, and patient groups. It’s reshaping the future of vision restoration. The market for smart retinal implants is growing due to the rising prevalence of vision impairments, technological advancements in retinal prosthetics, and increasing demand for solutions that restore vision in patients with retinal degenerative diseases.
The arteriovenous implants market continues to grow with supportive reimbursement policies, aging populations, and rising global prevalence of renal disorders. It’s reshaping the future of vascular access management. The market growth is attributed to rising ESRD prevalence, expanding hemodialysis populations, and continuous advancements in biomaterial-based vascular access technologies.
The RNA editing for neurodegenerative diseases market is driven by breakthroughs in RNA biology, delivery systems, and precision medicine. It represents a transformative approach to treating complex neurological conditions. The rapid advancements in RNA-based therapies, the increasing prevalence of neurodegenerative diseases, supportive government framework, and surge in healthcare expenditure are expected to drive the growth of the global RNA editing for neurodegenerative diseases market over the forecast period. In this global market, North America dominated the market, fuelled by the surge in clinical trials and the increasing presence of biotech hubs.
The rare disease small-batch CDMO market is driven by the rise of precision medicine and niche therapeutics. Specialized CDMOs support fast turnaround and high-quality production for rare conditions. The rare disease small-batch CDMO market has experienced significant growth in recent years, reflecting the increasing reliance on digital platforms for freelance and gig-based work. The small-batch CDMO market for rare diseases has seen remarkable growth recently, driven by the rising use of digital platforms for freelance and gig work. The market is valued with strong prospects for continued expansion.
The global LNP CDMO market size was calculated at USD 205.47 million in 2024 and is predicted to increase from USD 235.98 million in 2025 to approximately USD 820.46 million by 2034, expanding at a CAGR of 14.85% from 2025 to 2034. The market is experiencing substantial growth due to the increasing demand for delivery systems, especially in the development of mRNA-based vaccines and therapeutics. This growth is further supported by the rising trend of biopharma companies outsourcing formulation and manufacturing services. Additionally, ongoing advancements in nanotechnology and the expanding applications of LNPs in gene therapy and oncology are expected to accelerate market expansion.
The orphan disease biomarkers market is witnessing strong growth as healthcare systems focus on early detection of rare diseases. Biomarkers help accelerate diagnosis and enable targeted therapies. The market is growing due to the rising demand for early and precise diagnostic tools that support the development of targeted therapies for rare diseases.
The global biomarker discovery outsourcing services market size accounted for USD 14.57 billion in 2024 and is predicted to increase from USD 17.42 billion in 2025 to approximately USD 86.74 billion by 2034, expanding at a CAGR of 19.53% from 2025 to 2034. The market is experiencing steady growth, driven by rising precision medicine demand and advanced diagnostic innovations.
The global tocotrienol market size was calculated at USD 386.06 million in 2024 and is predicted to increase from USD 409.84 million in 2025 to approximately USD 701.88 million by 2034, expanding at a CAGR of 6.16% from 2025 to 2034. The market is experiencing steady growth, driven by rising health awareness, nutraceutical adoption, and expanding applications.
The global ovine and caprine artificial insemination market size accounted for USD 1.25 billion in 2024 and is predicted to increase from USD 1.33 billion in 2025 to approximately USD 2.31 billion by 2034, expanding at a CAGR of 6.30% from 2025 to 2034. The market for artificial insemination in ovine and caprine (sheep and goats) is experiencing substantial growth, driven by increasing demand for genetic improvement. This growth is further supported by the adoption of advanced breeding techniques aimed at enhancing productivity and disease resistance. Additionally, expanding applications in livestock management and dairy production are expected to fuel market expansion.
The global metabolomics market size was calculated at USD 3.77 billion in 2024 and is predicted to increase from USD 4.31 billion in 2025 to approximately USD 14.40 billion by 2034, expanding at a CAGR of 14.34% from 2025 to 2034. The metabolomics market has experienced significant growth in recent years, reflecting the increasing reliance on digital platforms for freelance and gig-based work. As of 2024, the market size is estimated at USD 3.77 billion, with rapid expansion projected into the coming years. The metabolomics market is an emerging field of life science focused on the comprehensive study of metabolites within cells, tissues, and biofluids. It plays a critical role in understanding biochemical pathways and uncovering biomarkers.
The global digestive diamine oxidase enzyme for supplements market size accounted for USD 25.22 million in 2024 and is predicted to increase from USD 26.66 million in 2025 to approximately USD 43.87 million by 2034, expanding at a CAGR of 5.69% from 2025 to 2034. The market is driven by rising cases of histamine intolerance, growing demand for gut health solutions, and increasing consumer preference for natural digestive support products.
The global biopharmaceutical packaging market size was calculated at USD 95.35 billion in 2024 and is predicted to increase from USD 101.59 billion in 2025 to approximately USD 179.66 billion by 2034, expanding at a CAGR of 6.54% from 2025 to 2034. The biopharmaceutical packaging market is poised for significant growth, with projections indicating a notable increase in market size over the next decade, reflecting the growing importance of innovative packaging solutions in the biopharmaceutical industry.
The global protein characterization and identification market size was calculated at USD 4.80 billion in 2024 and is predicted to increase from USD 5.05 billion in 2025 to approximately USD 8.04 billion by 2034, expanding at a CAGR of 5.29% from 2025 to 2034. The market is growing due to increasing demand for advanced analytical techniques in drug development, biotechnology research, and quality control across pharmaceuticals and life sciences.
The global healthcare payer network management market size accounted for USD 5.04 billion in 2024 and is predicted to increase from USD 5.72 billion in 2025 to approximately USD 17.98 billion by 2034, expanding at a CAGR of 13.56% from 2025 to 2034. The market growth is attributed to rising digital health adoption, government-driven interoperability mandates, and increasing investments in advanced payer IT infrastructure.
The global IV bags market size was calculated at USD 4.13 billion in 2024 and is predicted to increase from USD 4.36 billion in 2025 to approximately USD 7.20 billion by 2034, expanding at a CAGR of 5.73% from 2025 to 2034. The IV bags market is seen to reach milestones with the emergence of environmentally friendly material in the sector.
The synthetic biology for industrial enzymes market is witnessing growth as industries seek eco-friendly alternatives. Customized enzymes enable cleaner manufacturing, energy savings, and reduced environmental impact. The market is growing due to rising demand for sustainable, efficient, and cost-effective enzyme production across industries such as food, biofuels, and pharmaceuticals.
The global microbiome manufacturing market size accounted for USD 26.98 billion in 2024 and is predicted to increase from USD 31.59 billion in 2025 to approximately USD 130.37 billion by 2034, expanding at a CAGR of 17.06% from 2025 to 2034. The market growth is attributed to rising investments in microbiome research, regulatory approvals of live microbial therapeutics, and the expansion of GMP-compliant manufacturing capabilities.
The global pharmaceutical blister packaging market size accounted for USD 21.75 billion in 2024 and is predicted to increase from USD 23.41 billion in 2025 to approximately USD 45.46 billion by 2034, expanding at a CAGR of 7.65% from 2025 to 2034. Growth in e-pharmacies and demand for tamper-evident packaging solutions, innovation in cold form foil technology for improved drug protection, and generic drug manufacturing expansion are driving the growth of the pharmaceutical blister packaging market.
The omics sequencing market continues to expand with government funding, biopharma adoption, and innovations in next-generation sequencing platforms. The market is rapidly expanding, driven by advancements in genomics, proteomics, and transcriptomics, enabling precision medicine, drug discovery, and personalized healthcare solutions across diverse clinical and research applications worldwide.
The global pharmaceutical spray drying market size accounted for USD 2.38 billion in 2024 and is predicted to increase from USD 2.56 billion in 2025 to approximately USD 4.99 billion by 2034, expanding at a CAGR of 7.68% from 2025 to 2034. Rising adoption of spray drying in biopharma companies, rising prevalence of poorly water-soluble drugs, demand for high-quality products, and technological advancements are driving the growth of the market.
The global ophthalmic drug CDMO market is driven by innovation, outsourcing strategies, and the need for scalable solutions in ophthalmic drug development. The market is experiencing significant growth due to the rising demand for specialized ophthalmic formulations and outsourcing services. This growth is further supported by advancements in sterile manufacturing and the increasing development of complex drug delivery systems. Additionally, the rising prevalence of eye disorders and the need for cost-effective production are expected to drive market expansion.
The global clinical trial materials manufacturing market is expanding with growing demand for efficient supply chains and customized solutions in clinical research. The clinical trial material manufacturing market is expanding due to increased R&D investments, rising chronic disease prevalence, and the globalization of clinical trials, driving demand for efficient, compliant, and scalable supply solutions.
The global wearable biometric monitor market size was calculated at USD 10.72 billion in 2024 and is predicted to increase from USD 11.68 billion in 2025 to approximately USD 25.26 billion by 2034, expanding at a CAGR of 8.95% from 2025 to 2034. The market growth is attributed to rising health awareness, rapid adoption of AI-driven biosensors, and expanding integration of wearables into remote patient monitoring and chronic disease management.
The hormonal drug CDMO market is driven as pharmaceutical companies increasingly rely on specialized CDMOs to ensure quality, regulatory compliance, and efficient production of hormonal therapies. The market is growing due to the rising demand for outsourced manufacturing services driven by the increasing prevalence of hormonal disorders and the need for cost-efficient, specialized production capabilities.
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services. The oncology market is witnessing growth due to increasing awareness and quick diagnosis of cancer, which is enabling patients to treat themselves early.
The U.S. dental equipment market size accounted for USD 2.92 billion in 2024 and is predicted to increase from USD 3.18 billion in 2025 to approximately USD 7.17 billion by 2034, expanding at a CAGR of 9.40% from 2025 to 2034. The U.S. dental equipment market is growing due to shifting demographics with a growing aging population.
The global vaccine CDMO market size was calculated at USD 4.67 billion in 2024 and is predicted to increase from USD 5.09 billion in 2025 to approximately USD 11.16 billion by 2034, expanding at a CAGR of 9.10% from 2025 to 2034. The vaccine CDMO market is growing due to the raised funding from both the public as well as private sectors seeks to encourage innovations in vaccine design along with production processes.
The global autologous stem cell and non-stem cell based therapies market size accounted for USD 8.64 billion in 2024 and is predicted to increase from USD 9.64 billion in 2025 to approximately USD 25.78 billion by 2034, expanding at a CAGR of 11.55% from 2025 to 2034. The market is experiencing significant growth due to the rising prevalence of chronic and degenerative diseases, advancements in regenerative medicine, and the demand for personalized treatment approaches. Increased clinical research and a wider range of applications in orthopedic, cardiovascular, and neurological disorders are expected to further accelerate market growth.
The global predictive genetic counselling market size accounted for USD 2.85 billion in 2024 and is predicted to increase from USD 3.18 billion in 2025 to approximately USD 8.43 billion by 2034, expanding at a CAGR of 11.45% from 2025 to 2034. It combines clinical genetics, risk assessment, and psychological support to guide patients in making informed decisions about their health and future.
The global infectious disease vaccines market size accounted for USD 36.25 billion in 2024 and is predicted to increase from USD 38.83 billion in 2025 to approximately USD 72.40 billion by 2034, expanding at a CAGR of 7.17% from 2025 to 2034. The increased prevalence of infectious diseases and advancements in vaccine technology are driving the global market. The government initiatives and support are further contributing to the market growth.
The global gene editing & mRNA tool kits market witnessing rapid growth fueled by increased demand in healthcare, pharma, and life sciences R&D. The market is driven by rising demand for advanced research tools in precision medicine, cell therapy, and drug discovery.
The global C5 complement inhibitors market size accounted for USD 4.25 billion in 2024 and is predicted to increase from USD 4.85 billion in 2025 to approximately USD 16.01 billion by 2034, expanding at a CAGR of 14.18% from 2025 to 2034. The market is significantly growing due to the increased rate of rare and fatal diseases that need C5 inhibitor-based treatment, growing research and development in developed countries for innovative inhibitors, and advancement in the biotechnology area.
The high-potency API (HPAPI) CDMO market is accelerating as pharmaceutical companies focus on oncology, hormonal therapies, and niche drugs, driving demand for specialized manufacturing expertise. The high-potency API (HPAPI) CDMO market is a rapidly growing segment within the pharmaceutical industry, driven by increasing demand for specialized drug manufacturing services. With a strong projected growth trajectory, this market is expected to expand significantly over the coming decade, reflecting its vital role in advanced medical therapies.
The global GLP-1 analogues market size was calculated at USD 49.90 billion in 2024 and is predicted to increase from USD 66.48 billion in 2025 to approximately USD 879.90 billion by 2034, expanding at a CAGR of 33.24% from 2025 to 2034. The market is growing due to the rising prevalence of diabetes and obesity, driving demand for effective treatment options.
The global liquid nefopam hydrochloride market growth is influenced by research in safer analgesic therapies and rising surgical procedures. The market is growing due to increasing demand for convenient, fast-acting, and easily administrable pain relief formulations.
The global aseptic fill-finish manufacturing market size accounted for USD 5.95 billion in 2024 and is predicted to increase from USD 6.48 billion in 2025 to approximately USD 14.01 billion by 2034, expanding at a CAGR of 8.94% from 2025 to 2034.
The global scalp micropigmentation services market size accounted for USD 2.63 billion in 2024 and is predicted to increase from USD 2.80 billion in 2025 to approximately USD 4.88 billion by 2034, expanding at a CAGR of 6.37% from 2025 to 2034. The market for scalp micropigmentation services has experienced significant growth and is expected to continue expanding over the coming years.
The global pressure guidewires market size accounted for USD 573.48 million in 2024 and is predicted to increase from USD 621.86 million in 2025 to approximately USD 1,293.34 million by 2034, expanding at a CAGR of 8.48% from 2025 to 2034. It plays a crucial role in industries where safe and precise operations are essential, such as oil and gas, chemical processing, pharmaceuticals, and manufacturing.
The global fractional flow reserve market size was calculated at USD 0.97 billion in 2024 and is predicted to increase from USD 1.06 billion in 2025 to approximately USD 2.37 billion by 2034, expanding at a CAGR of 9.34% from 2025 to 2034. The market growth is attributed to increased risk of cardiovascular diseases due to lifestyle and dietary factors, increasing demand for evidence-based diagnostics, and rapid adoption of AI-driven imaging technologies.
The next-generation RNA therapeutics market is poised for strong growth as mRNA, siRNA, and antisense technologies enable innovative therapies for complex and previously untreatable diseases. The market growth is attributed to rising institutional funding and expanding applications of RNA platforms in oncology, rare genetic disorders, and infectious disease therapeutics.
The global real-time location systems market size was calculated at USD 5.23 billion in 2024 and is predicted to increase from USD 6.49 billion in 2025 to approximately USD 45.13 billion by 2034, expanding at a CAGR of 24.05% from 2025 to 2034. The market is driven by rapid urbanization, rising need for advanced security systems, rising use of smartphones and mobile gaming, and rapid growth in adoption in the healthcare segment.
The global myopia treatment devices market size accounted for USD 18.07 billion in 2024 and is predicted to increase from USD 19.49 billion in 2025 to approximately USD 38.51 billion by 2034, expanding at a CAGR of 7.86% from 2025 to 2034. This market is growing due to the rising prevalence of vision disorders among younger populations and the increasing adoption of advanced corrective technologies.
The psoriatic arthritis therapeutics drugs market is evolving rapidly with innovation in biosimilars, small molecules, and personalized medicine improving treatment outcomes. The market growth is attributed to rising psoriatic arthritis prevalence, expanding access to biologics and targeted oral therapies, and supportive regulatory approvals enhancing treatment adoption.
The global hyaluronic acid personal care products market size was estimated at USD 3.61 billion in 2024 and is predicted to increase from USD 3.92 billion in 2025 to approximately USD 8.34 billion by 2034, expanding at a CAGR of 8.74% from 2025 to 2034. The market for hyaluronic acid personal care products has experienced a massive spike in growth during recent years, reflecting increasing consumer awareness and demand for skincare and beauty products containing this popular ingredient. As we look to the future, the market is expected to continue its expansion, driven by innovations and expanding applications across the personal care industry.
The global flexible electronics in healthcare market size accounted for USD 7.00 billion in 2024 and is predicted to increase from USD 8.40 billion in 2025 to approximately USD 43.57 billion by 2034, expanding at a CAGR of 20.70% from 2025 to 2034. The rising prevalence of chronic diseases, growing demand for wearable health monitors, increasing consumer preference for biosensor-equipped smart clothing, and rapid technological innovation are expected to boost the growth of the global flexible electronics in healthcare market over the forecast period. Several prominent players are widely adopting effective strategies like new product launches and mergers to gain a competitive edge and strengthen their market share. Additionally, the market is expanding in emerging regions, particularly the Asia Pacific, fueled by the presence of key market players and the expansion of production & manufacturing capacity of flexible electronics.
The global glycyrrhiza glabra licorice root extract market size accounted for USD 2.15 billion in 2024 and is predicted to increase from USD 2.28 billion in 2025 to approximately USD 3.87 billion by 2034, expanding at a CAGR of 6.05% from 2025 to 2034. The market is experiencing significant growth due to the increasing demand for herbal and natural ingredients in pharmaceuticals, cosmetics, and food products. This growth is further supported by the anti-inflammatory, antioxidant, and antimicrobial properties of these ingredients. Additionally, the rising use of herbal products in skincare, respiratory health supplements, and functional foods is expected to drive market expansion.
The global vitamin B-complex ingredients market size accounted for USD 3.35 billion in 2024 and is predicted to increase from USD 3.49 billion in 2025 to approximately USD 5.01 billion by 2034, expanding at a CAGR of 4.11% from 2025 to 2034. Increasing awareness about vitamin B complex and its crucial functions in the body, prevalence of diseases due to low immunity, vitamin deficiency, and innovative healthcare product launches by several key players in the market are driving factors for the market.
The global reusable laparoscopic instruments market size accounted for USD 3.27 billion in 2024 and is predicted to increase from USD 3.49 billion in 2025 to approximately USD 6.28 billion by 2034, expanding at a CAGR of 6.74% from 2025 to 2034. The market is driven by the rising demand for minimally invasive surgeries, the increasing prevalence of chronic diseases, and the cost-effectiveness of reusable laparoscopic instruments.
The global rifaximin market size accounted for USD 1.84 billion in 2024 and is predicted to increase from USD 2.04 billion in 2025 to approximately USD 5.09 billion by 2034, expanding at a CAGR of 10.72% from 2025 to 2034. The increased awareness about effective treatment options for gastrointestinal disease and demand for non-systemic antibiotics, like rifaximin driving the market.
The global non-sterile liquids and suspensions market size accounted for USD 48.06 million in 2024 and is predicted to increase from USD 51.46 million in 2025 to approximately USD 95.25 million by 2034, expanding at a CAGR of 7.08% from 2025 to 2034. The market for non-sterile liquids and suspensions is driven by rising demand for oral medications, ease of administration, pediatric and geriatric preference, cost-effectiveness, expanding pharmaceutical production, and increasing prevalence of chronic diseases.
The global pulmonary alveolar proteinosis (PAP) drugs market size was estimated at USD 750.05 million in 2024 and is predicted to increase from USD 802.70 million in 2025 to approximately USD 1,478.22 million by 2034, expanding at a CAGR of 7.02% from 2025 to 2034. The market is experiencing significant growth due to the rising prevalence of rare lung disorders and a heightened focus on targeted therapies. This growth is further supported by advancements in biologics and the development of both inhaled and systemic treatment options. Additionally, an increase in clinical research and orphan drug designations is expected to further accelerate market expansion.
The global nefopam hydrochloride injection market size accounted for USD 120.06 billion in 2024 and is predicted to increase from USD 129 billion in 2025 to approximately USD 246.30 billion by 2034, expanding at a CAGR of 7.45% from 2025 to 2034. The increased demand for non-opioid analgesics is driving the adoption of nefopam hydrochloride injections, leading to an expansion of the market acceptability and availability. Additionally, the ongoing advancements in drug delivery systems are further contributing to the increasing adoption of nefopam hydrochloride injections globally, particularly in Europe, the Asia Pacific, and Latin America.
The global patient telemonitoring systems market is shaped by regulatory support and technological advancements in wearable and connected health devices.The growing rate of chronic diseases globally, technological advancements like AI/ML and its integration into healthcare systems, increasing shift to online consulting are driving factors of the patient telemonitoring systems market.
The global laser-based 3D bioprinting market size was calculated at USD 1.54 billion in 2024 and is predicted to increase from USD 1.79 billion in 2025 to approximately USD 7.11 billion by 2034, expanding at a CAGR of 16.53% from 2025 to 2034. The rapid growth of the laser-based 3D bioprinting market is driven by growing need for organ and tissue regeneration, pharmaceutical drug testing, and ongoing improvements in laser precision and biocompatible materials.
The global penicillin G acylase market size accounted for USD 150.05 million in 2024 and is predicted to increase from USD 158.39 million in 2025 to approximately USD 257.77 million by 2034, expanding at a CAGR of 5.56% from 2025 to 2034. The growing demand for semi-synthetic antibiotics, rapid advancements in enzyme immobilization technologies, growing demand for enzyme-based manufacturing processes, and increasing popularity of sustainable production methods are expected to drive the growth of the global market for penicillin G acylase over the forecast period. Several key players in the market are widely adopting effective strategies to expand their market share and gain a competitive edge. Additionally, the market is expanding in emerging regions, particularly North America, fuelled by increasing healthcare expenditure and a surge in research activities.
The global cardiotoxicity screening market size accounted for USD 2.84 billion in 2024 and is predicted to increase from USD 3.17 billion in 2025 to approximately USD 8.46 billion by 2034, expanding at a CAGR of 11.54% from 2025 to 2034. The increased demand for effective and precise cardiotoxicity screening methods is driving the global market. The growing awareness about drug safety is further contributing to this demand.
The global ceftazidime-avibactam market size accounted for USD 3.3 billion in 2024 and is predicted to increase from USD 3.56 billion in 2025 to approximately USD 7.15 billion by 2034, expanding at a CAGR of 8.05% from 2025 to 2034. The market for ceftazidime-avibactam is experiencing substantial growth due to the rising incidence of multidrug-resistant gram-negative infections, which is driving its demand in clinical settings. This demand is further reinforced by its effectiveness in treating complicated intra-abdominal and urinary tract infections. Increasing hospital utilization and heightened awareness of antimicrobial resistance are expected to accelerate market expansion.
The global cables for endoscopes market size accounted for USD 1.26 billion in 2024 and is predicted to increase from USD 1.37 billion in 2025 to approximately USD 3.00 billion by 2034, expanding at a CAGR of 9.06% from 2025 to 2034. The market is showing steady growth with the developments in imaging technology used in the medical field, growing demand for minimally invasive surgery, and spending growth in healthcare and healthcare infrastructure, indicating an overall positive prognosis for the market.
The global biopsy bag market size accounted for USD 1.25 billion in 2024 and is predicted to increase from USD 1.37 billion in 2025 to approximately USD 3.11 billion by 2034, expanding at a CAGR of 9.54% from 2025 to 2034. The market is driven by rising cancer prevalence, increasing biopsy procedures, and growing demand for safe and contamination-free specimen handling.
The global pentoxifylline drug market size accounted for USD 450.06 million in 2024 and is predicted to increase from USD 479.49 million in 2025 to approximately USD 848.00 million by 2034, expanding at a CAGR of 6.54% from 2025 to 2034. The market is experiencing substantial growth due to the increasing prevalence of peripheral artery diseases and chronic blood circulation disorders. This demand is further supported by pentoxifylline’s effectiveness in improving blood flow and alleviating the symptoms of vascular conditions. Additionally, its growing relevance in managing diabetic neuropathy and other microcirculatory complications is expected to drive market expansion.
The global PEGylation proteins technology market size accounted for USD 4.56 billion in 2024 and is predicted to increase from USD 4.89 billion in 2025 to approximately USD 9.17 billion by 2034, expanding at a CAGR of 7.24% from 2025 to 2034. The market growth is attributed to rising demand for long-acting biologics that enhance patient adherence and reduce treatment burden through PEGylation-enabled drug delivery.
